Frost & Sullivan Release: Adapt and Defend: Strategies to Sustain the ELISA Market in Face of Multiplex Shift

PALO ALTO, Calif.--(BUSINESS WIRE)--The Drug Discovery & Clinical Diagnostics Group at Frost & Sullivan is pleased to announce its 2008 Quarterly Analyst Briefing Presentation on the ELISA market to be held on Thursday, April 17, 2008 at 12:00 p.m. CDT / 1:00 p.m. EDT.

MORE ON THIS TOPIC